These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12709320)

  • 1. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.
    Gauthier C; Weber S; Alarco AM; Alqawi O; Daoud R; Georges E; Raymond M
    Antimicrob Agents Chemother; 2003 May; 47(5):1543-54. PubMed ID: 12709320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin.
    Schuetzer-Muehlbauer M; Willinger B; Krapf G; Enzinger S; Presterl E; Kuchler K
    Mol Microbiol; 2003 Apr; 48(1):225-35. PubMed ID: 12657057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.
    Smriti ; Krishnamurthy S; Dixit BL; Gupta CM; Milewski S; Prasad R
    Yeast; 2002 Mar; 19(4):303-18. PubMed ID: 11870854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
    Shukla S; Ambudkar SV; Prasad R
    J Antimicrob Chemother; 2004 Jul; 54(1):38-45. PubMed ID: 15190023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR; Tsao S; Ong SW; Lamping E; Niimi K; Monk BC; Niimi M; Kaneko A; Holland BR; Schmid J; Cannon RD
    Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
    Tanabe K; Lamping E; Nagi M; Okawada A; Holmes AR; Miyazaki Y; Cannon RD; Monk BC; Niimi M
    Mol Microbiol; 2011 Oct; 82(2):416-33. PubMed ID: 21895791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.
    Basso LR; Gast CE; Mao Y; Wong B
    Eukaryot Cell; 2010 Jun; 9(6):960-70. PubMed ID: 20348384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.
    Wakiec R; Gabriel I; Prasad R; Becker JM; Payne JW; Milewski S
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4057-63. PubMed ID: 18794383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
    Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
    Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.
    Coste AT; Karababa M; Ischer F; Bille J; Sanglard D
    Eukaryot Cell; 2004 Dec; 3(6):1639-52. PubMed ID: 15590837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of Candida albicans ABC transporter Cdr1p.
    Shukla S; Saini P; Smriti ; Jha S; Ambudkar SV; Prasad R
    Eukaryot Cell; 2003 Dec; 2(6):1361-75. PubMed ID: 14665469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.